Company / Operating Income per Share
X4 Pharmaceuticals, Inc Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$18.87
FY2025
5-year range
-$18.87 / -$0.52
FY2021-FY2025
Trend
-3507.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -3508% YoY in FY2025, a notable deviation from the 5-year average annual change of -696%.
Based on SEC 10-K filings.
-18.87 in FY2025.
Declined from $-2.13 to $-18.87 over the past 3 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 3507.9% year-over-year.
- Peak operating income per share was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$18.87 | -3507.9% |
| FY2024 | -$0.52 | +75.4% |
| FY2022 | -$2.13 | +32.9% |
| FY2021 | -$3.17 | -75.8% |
| FY2020 | -$1.80 | -5.9% |
| FY2018 | -$1.70 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026